Ken Chen
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer-related Molecular Pathways
Papers in
-
- Single-cell and spatial transcriptomics 32
- Genomics and Phylogenetic Studies 14
- Gene expression and cancer classification 11
-
- Cancer Genomics and Diagnostics 54
- Co-authors
- Li Ding (18 shared papers)David E. Larson (6 shared papers)Richard K. Wilson (9 shared papers)Elaine R. Mardis (8 shared papers)Michael D. McLellan (6 shared papers)Nicholas E. Navin (16 shared papers)Daniel C. Koboldt (5 shared papers)Ronald A. DePinho (5 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Nature Communications (8 papers)Oncotarget (7 papers)Blood (6 papers)Bioinformatics (6 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Ken Chen
304 papers receiving 11.6k citations
Ken Chen's Hit Papers
Peers
Comparison fields: 5 of 200
- Cancer Research 2.6k
- Oncology 2.3k
- Molecular Biology 5.7k
- Genetics 1.7k
- Immunology 794
Countries citing papers authored by Ken Chen
This map shows the geographic impact of Ken Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Chen more than expected).
Fields of papers citing papers by Ken Chen
This network shows the impact of papers produced by Ken Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Chen. The network helps show where Ken Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 326 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 Hit paper breakdown → | 1998 | 1321 |
| 2 | BreakDancer: an algorithm for high-resolution mapping of genomic structural variation Hit paper breakdown → | 2009 | 1048 |
| 3 | VarScan: variant detection in massively parallel sequencing of individual and pooled samples Hit paper breakdown → | 2009 | 954 |
| 4 | Clonal evolution in breast cancer revealed by single nucleus genome sequencing Hit paper breakdown → | 2014 | 745 |
| 5 | Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes Hit paper breakdown → | 2021 | 468 |
| 6 | 2011 | 399 | |
| 7 | 2017 | 218 | |
| 8 | 2005 | 208 | |
| 9 | 1998 | 171 | |
| 10 | 2013 | 157 | |
| 11 | 2006 | 151 | |
| 12 | 2022 | 144 | |
| 13 | 2015 | 144 | |
| 14 | 2000 | 122 | |
| 15 | 2015 | 120 | |
| 16 | 2014 | 116 | |
| 17 | 2016 | 113 | |
| 18 | 2015 | 102 | |
| 19 | 2017 | 101 | |
| 20 | 2016 | 96 |
About Ken Chen
Ken Chen is a scholar working on Molecular Biology, Cancer Research, Computer Vision and Pattern Recognition, Artificial Intelligence and Oncology, having authored 326 papers that have together received 11.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (54 papers), Single-cell and spatial transcriptomics (32 papers), Speech Recognition and Synthesis (14 papers), Genomics and Phylogenetic Studies (14 papers), Genomics and Rare Diseases (13 papers), Gene expression and cancer classification (11 papers), Acute Myeloid Leukemia Research (10 papers) and Natural Language Processing Techniques (10 papers). The work is most often cited by research in Cancer Research (2.6k citations), Oncology (2.3k citations), Molecular Biology (5.7k citations), Genetics (1.7k citations) and Immunology (794 citations). Ken Chen has collaborated with scholars based in United States, China and France. Frequent co-authors include Li Ding, David E. Larson, Richard K. Wilson, Elaine R. Mardis, Michael D. McLellan, Nicholas E. Navin, Daniel C. Koboldt, Ronald A. DePinho, Nicole Schreiber‐Agus and Carlos Cordon‐Cardo. Their work appears in journals such as Journal of Clinical Oncology, Nature Communications, Oncotarget, Blood and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.